These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36194390)

  • 1. Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs.
    Luozhong S; Yuan Z; Sarmiento T; Chen Y; Gu W; McCurdy C; Gao W; Li R; Wilkens S; Jiang S
    Nano Lett; 2022 Oct; 22(20):8304-8311. PubMed ID: 36194390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine-Loaded Lipid Nanoparticles.
    Gomi M; Sakurai Y; Sato M; Tanaka H; Miyatake Y; Fujiwara K; Watanabe M; Shuto S; Nakai Y; Tange K; Hatakeyama H; Akita H
    Adv Healthc Mater; 2023 Apr; 12(9):e2202528. PubMed ID: 36535635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cell-Mimicking Nanoparticles Promote mRNA Delivery to Lymphoid Organs.
    Cao Y; Long J; Sun H; Miao Y; Sang Y; Lu H; Yu C; Zhang Z; Wang L; Yang J; Wang S
    Adv Sci (Weinh); 2023 Nov; 10(33):e2302423. PubMed ID: 37867227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of phosphatidylserine improves efficiency of lipid based gene delivery systems.
    Lotter C; Alter CL; Bolten JS; Detampel P; Palivan CG; Einfalt T; Huwyler J
    Eur J Pharm Biopharm; 2022 Mar; 172():134-143. PubMed ID: 35181492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-Rel expression in myeloid and lymphoid cells with distearoyl -phosphatidylserine (DSPS) liposomal nanoparticles encapsulating therapeutic siRNA.
    Bressy C; Zemani A; Goyal S; Jishkariani D; Lee CN; Chen YH
    PLoS One; 2022; 17(12):e0276905. PubMed ID: 36520934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic noncationic lipid nanoparticles for mRNA delivery.
    Wang C; Zhao C; Wang W; Liu X; Deng H
    Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2311276120. PubMed ID: 38079547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
    Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
    Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.
    LoPresti ST; Arral ML; Chaudhary N; Whitehead KA
    J Control Release; 2022 May; 345():819-831. PubMed ID: 35346768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.
    Jyotsana N; Sharma A; Chaturvedi A; Budida R; Scherr M; Kuchenbauer F; Lindner R; Noyan F; Sühs KW; Stangel M; Grote-Koska D; Brand K; Vornlocher HP; Eder M; Thol F; Ganser A; Humphries RK; Ramsay E; Cullis P; Heuser M
    Ann Hematol; 2019 Aug; 98(8):1905-1918. PubMed ID: 31104089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles.
    Ross-Thriepland D; Bornot A; Butler L; Desai A; Jaiswal H; Peel S; Hunter MR; Odunze U; Isherwood B; Gianni D
    SLAS Discov; 2020 Jul; 25(6):605-617. PubMed ID: 32441189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection.
    Tuma J; Chen YJ; Collins MG; Paul A; Li J; Han H; Sharma R; Murthy N; Lee HY
    Biochemistry; 2023 Dec; 62(24):3533-3547. PubMed ID: 37729550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System.
    Pattipeiluhu R; Arias-Alpizar G; Basha G; Chan KYT; Bussmann J; Sharp TH; Moradi MA; Sommerdijk N; Harris EN; Cullis PR; Kros A; Witzigmann D; Campbell F
    Adv Mater; 2022 Apr; 34(16):e2201095. PubMed ID: 35218106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery.
    Wang X; Yu B; Wu Y; Lee RJ; Lee LJ
    Anticancer Res; 2011 May; 31(5):1619-26. PubMed ID: 21617218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol.
    Rafique A; Etzerodt A; Graversen JH; Moestrup SK; Dagnæs-Hansen F; Møller HJ
    Int J Nanomedicine; 2019; 14():2829-2846. PubMed ID: 31114197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Intracellular Biology to Improve mRNA Delivery by Lipid Nanoparticles.
    Hunter MR; Cui L; Porebski BT; Pereira S; Sonzini S; Odunze U; Iyer P; Engkvist O; Lloyd RL; Peel S; Sabirsh A; Ross-Thriepland D; Jones AT; Desai AS
    Small Methods; 2023 Sep; 7(9):e2201695. PubMed ID: 37317010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression.
    Sayers EJ; Peel SE; Schantz A; England RM; Beano M; Bates SM; Desai AS; Puri S; Ashford MB; Jones AT
    Mol Ther; 2019 Nov; 27(11):1950-1962. PubMed ID: 31427168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.